Pharmacokinetics of amoxicillin in subjects with normal and impaired renal function. 1982

A Arancibia, and M T Drouguett, and G Fuentes, and G González, and C González, and S Thambo, and G Palombo

The pharmacokinetics of amoxicillin was investigated in 4 healthy volunteers and in 16 patients with varying degrees of renal impairment, 4 of whom were on regular hemodialysis. Amoxicillin was administered both in a 1-g single intravenous injection and two 500-mg capsules per os. The kinetics of the antibiotic followed an open two-compartment model. In the patients with renal failure there was a significant decrease in beta, kappa10, and total body clearance. A linear relationship between beta of amoxicillin and creatinine clearance was found. This relationship allows dosage regimen adjustment for patients with renal impairment. A significant increase in the absorption half-life of the antibiotic was also observed in patients with renal impairment. The half-life of the antibiotic during hemodialysis was 2.3 h.

UI MeSH Term Description Entries
D007674 Kidney Diseases Pathological processes of the KIDNEY or its component tissues. Disease, Kidney,Diseases, Kidney,Kidney Disease
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003404 Creatinine Creatinine Sulfate Salt,Krebiozen,Salt, Creatinine Sulfate,Sulfate Salt, Creatinine
D005260 Female Females
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

A Arancibia, and M T Drouguett, and G Fuentes, and G González, and C González, and S Thambo, and G Palombo
January 1990, Antimicrobial agents and chemotherapy,
A Arancibia, and M T Drouguett, and G Fuentes, and G González, and C González, and S Thambo, and G Palombo
November 1991, Antimicrobial agents and chemotherapy,
A Arancibia, and M T Drouguett, and G Fuentes, and G González, and C González, and S Thambo, and G Palombo
October 1980, European journal of clinical pharmacology,
A Arancibia, and M T Drouguett, and G Fuentes, and G González, and C González, and S Thambo, and G Palombo
March 1980, Antimicrobial agents and chemotherapy,
A Arancibia, and M T Drouguett, and G Fuentes, and G González, and C González, and S Thambo, and G Palombo
September 1980, The Journal of antimicrobial chemotherapy,
A Arancibia, and M T Drouguett, and G Fuentes, and G González, and C González, and S Thambo, and G Palombo
March 2008, Journal of clinical pharmacology,
A Arancibia, and M T Drouguett, and G Fuentes, and G González, and C González, and S Thambo, and G Palombo
January 1978, Antibiotics and chemotherapy,
A Arancibia, and M T Drouguett, and G Fuentes, and G González, and C González, and S Thambo, and G Palombo
June 1981, Antimicrobial agents and chemotherapy,
A Arancibia, and M T Drouguett, and G Fuentes, and G González, and C González, and S Thambo, and G Palombo
November 1988, Arzneimittel-Forschung,
A Arancibia, and M T Drouguett, and G Fuentes, and G González, and C González, and S Thambo, and G Palombo
January 2000, British journal of clinical pharmacology,
Copied contents to your clipboard!